Ubald Kragten is currently heading the Business & Market Intelligence group within the DSM Innovation Center. In this role he and his team are strongly involved in shaping the Innovation Portfolio within the DSM Innovation Center with a strong focus on identifying new growth areas for DSM, defining strategies to enter these areas and developing strategies and key market insights for the selected growth areas which are ranging from renewable energy related topics into nutrition and advanced materials related areas. Prior to this he was responsible for business intelligence within DSM Fine Chemicals dealing with both internal as well as external orientated projects with subjects varying from strategy development, performance measurement and business reorganization programs towards marketing and pricing strategies for existing and new products.

Specialties: Strategy development, innovation, competitive analysis, business analysis, market research and business plan development

Royal DSM is a global science-based company active in health, nutrition and materials. By connecting its unique competences in Life Sciences and Materials Sciences DSM is driving economic prosperity, environmental progress and social advances to create sustainable value for all stakeholders simultaneously. DSM delivers innovative solutions that nourish, protect and improve performance in global markets such as food and dietary supplements, personal care, feed, medical devices, automotive, paints, electrical and electronics, life protection, alternative energy and bio-based materials. DSM and its associated companies deliver annual net sales of about €10 billion with approximately 25,000 employees. The company is listed on Euronext Amsterdam.